Galactorrhea during escitalopram treatment: A case report

Key Findings & Data:We were able to find only a very few reports which were involved with the effect on the prolactin level of a novel SSRI Escitalopram.

💡

Conclusion & Impact:Here we present a case that had high prolactin levels and galactorrhea during escitalopram treatment.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Hyperprolactinemia can be seen as an adverse effect during SSRI treatments. We were able to find only a very few reports which were involved with the effect on the prolactin level of a novel SSRI Escitalopram. Here we present a case that had high prolactin levels and galactorrhea during escitalopram treatment.

Özet

Essitalopram, seçici serotonin gerialım inhibitörlerinden (SSG‹) biridir. Hiperprolaktinemi, seçici serotonin gerialım inhibitörlerinin kullanımı sırasında ortaya çıkabilen bir yan etkidir. Essitalopramın prolaktin düzeyine etkisi ile ilgili çok az araştırmaya rastlanabilmiştir. Bu yazıda, essitalopram tedavisi almakta iken serum prolaktin artışı ve galaktore saptanan bir olgu sunulmuştur.

🔖

Cite This Article

EVRENSEL, A., GÜLSÜN, M., VERİM, S. (2022). Galactorrhea during escitalopram treatment: A case report. Klinik Psikofarmakoloji Bülteni, Cilt: 16 - Sayı: 1, 39–41. https://ajindex.com/articles/574393

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Feuchtl A, Bagli M, Stephan R, Frahnert C, Kolsch H, Kuhn KU, Rao ML. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile, Pharmacopsychiatry 2004;37:180-188 2. Meltzer H, Bastani B, Jayathilake K, Maes M. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-Hydroxytryptophanmediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 1997;17-21 3. Checkley S. Neuroendocrine effects of psychotropic drugs. Bailliere's Clinical Endocrinology and Metabolism 1991;5;15-33 4. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Br J Psychiatry 2003;182:199-204 5. Bronzo MR, Stahl SM. Galactorrhea induced by sertraline (letter). Am J Psychiatry 1993;150:1269-1270 6. Hall MJ, Breast tenderness and enlargement induced by sertraline. Am J Psychiatry 1994;151:159 7. Peterson MC. Reversible galactorrhea and prolactin elevation related to fluoxetine use. Mayo Clin Proc 2001;76:215-216 8. Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5- HT2A receptor status. J Clin Psychopharmacol 1997;17:292-297 9. Nadeem HS, Attenburrow MJ, Cowen PJ. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses. Neuropsychopharmacology 2004; 29:1699-1703 10. Çorapçıoğlu A, Aydemir Ö, Yıldız M, Esen A, Köroğlu E. DSM-IV Eksen I Bozuklukları (SCID-I) için Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Ankara: Hekimler Yayın Birliği, 1999 11. Reichlin S. Neuroendocrinology. In:Wilson JD, Foster DW, eds. Textbook of endocrinology, 7th ed. Philadelphia: Sounders, 1985:492-567 12. Cooper DS, Gelenberg AJ, Wojcik JC, Saxe VC, Ridgway C, Maloof F. The effect of amoxapine and imipramine on serum prolactin levels. Ann Intern Med 1981;141:1023-1025 13. Golden RN, Ruegg R, Brown TW, Haggerty J, Garbutt JC, Pedersen CA, Evans DL. Abnormal neuroendocrine responsivity to clomipramine in depression. Psychopharmacol Bull 1990;26:317-320 14. Jorgensen H, Knigge U, Warberg J. Involvement of the 5-HT1, 5- HT2 and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5 hydroxytryptophan. Neuroendocrinology 1992;55:336-343 15. Lowy MT, Meltzer HY. Stimulation of serum cortizol and prolactin secr